Overall, these findings support a model in which Chlamydia pneumoniae acts as a disease amplifier in vulnerable retina–brain circuits and highlight pathogen- and NLRP3-targeted strategies, including timely antibiotic and inflammasome-modulating interventions, as testable avenues to modify AD progression. Here, NLRP3 is linked to Alzheimer disease.